posted on 2014-06-26, 00:00authored byYasser
M. Loksha, Erik B. Pedersen, Roberta Loddo, Giuseppina Sanna, Gabriella Collu, Gabriele Giliberti, Paolo La Colla
Novel analogues of MKC442 (6-benzyl-1-(ethoxymethyl)-5-isopropylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione) were synthesized by reaction
of 6-[(3,5-dimethylphenyl)fluoromethyl]-5-ethyluracil (<b>5</b>) with ethoxymethyl chloride and formaldehyde acetals. The Sonogashira
reaction was carried out on the <i>N</i>1-(<i>p</i>-iodobenzyl)oxy]methyl derivative of compound <b>5</b> using
propagyl alcohol to afford compound <b>12</b> (YML220). The
latter compound was selected for further studies since it showed the
most potent and selective activity in vitro against wild-type HIV-1
and non-nucleoside reverse transcriptase inhibitor-, nucleoside reverse
transcriptase inhibitor-, and protease inhibitor-resistant mutants
and a wide range of HIV-1 clinical isolates. <b>12</b> also
showed microbicidal activity in long-term assays with heavily infected
MT-4 cells.